147 related articles for article (PubMed ID: 36152343)
1. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
[TBL] [Abstract][Full Text] [Related]
2. Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.
Mahlooji I; Shokri M; Manoochehri R; Mahboubi-Rabbani M; Rezaee E; Tabatabai SA
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000052. PubMed ID: 32484272
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
Karami L; Saboury AA; Rezaee E; Tabatabai SA
Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
[TBL] [Abstract][Full Text] [Related]
4. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K
Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964
[TBL] [Abstract][Full Text] [Related]
6. Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.
Tian Y; Li S; Dong K; Su X; Fu S; Lv X; Duan M; Yang T; Han Y; Hu G; Liu J; Sun Y; Yue H; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Liu Y; Qin M; Gong P; Hou Y; Gao Z; Zhao Y
Bioorg Chem; 2022 Oct; 127():105898. PubMed ID: 35792317
[TBL] [Abstract][Full Text] [Related]
7. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
Hejazi L; Rezaee E; Tabatabai SA
Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel heterocyclic amide-based inhibitors: an integrative
Fakhar Z; Hejazi L; Tabatabai SA; Munro OQ
J Biomol Struct Dyn; 2022 Sep; 40(15):7114-7128. PubMed ID: 33650467
[TBL] [Abstract][Full Text] [Related]
10. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.
Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649
[TBL] [Abstract][Full Text] [Related]
11. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
[TBL] [Abstract][Full Text] [Related]
12. Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation.
Chen H; Zhang Y; Li L; Han JG
J Phys Chem B; 2012 Aug; 116(34):10219-33. PubMed ID: 22857012
[TBL] [Abstract][Full Text] [Related]
13. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
Du F; Sun W; Morisseau C; Hammock BD; Bao X; Liu Q; Wang C; Zhang T; Yang H; Zhou J; Xiao W; Liu Z; Chen G
Eur J Med Chem; 2021 Nov; 223():113678. PubMed ID: 34218083
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
[TBL] [Abstract][Full Text] [Related]
15. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
Çapan İ; Jordan PM; Olğaç A; Çalışkan B; Kretzer C; Werz O; Banoglu E
ChemMedChem; 2022 Jun; 17(12):e202200137. PubMed ID: 35466565
[TBL] [Abstract][Full Text] [Related]
18. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW
Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]